First News

Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market. The  immunohistochemistry market  is projected to reach USD 2.12 billion by 2021, at a CAGR of 7.3% during the forecast period.  Antibodies segment to dominate the global immunohistochemistry market Based on products, the market is segmented into antibodies, reagents, kits, and equipment. In 2015, the antibodies segment accounted for the largest share of the global immunohistochemistry market. The rising adoption of high-throughput assays, such as array comparative genomic hybridization, cDNA microarray, next-generation sequenci...

The  immunohistochemistry market  is projected to reach  USD 2.12 billion by 2021 , growing at a  CAGR of 7.3%  during the forecast period. Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the IVD industry, and increasing healthcare spending are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine are expected to offer significant growth opportunities for players in the market. Regulatory restrictions in developed countries, however, are a major challenge faced by market players in the current immunohistochemistry market. Antibodies segment to dominate the global immunohistochemistry market Based on products, the market is segmented into antibodies, reagents, kits, and equipment. In 2015, the antibodies segment accounted for the largest share of the global immunohist...

Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physician awareness & demand for histopathology are expected to fuel the growth of this market in the coming years. Rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market. What is growth in Immunohistochemistry Market   ? The  global immunohistochemistry market  is projected to reach $2.12 billion by 2021, at a CAGR of 7.3%. However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine offer significant growth opportunities in the immunohistochemistry market. Objectives of the study: To define, describe, and forecast the global immunohistochemistry market on the basis of product, application, and end user To provide detailed informa...

Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the IVD industry, and increasing healthcare spending are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine are expected to offer significant growth opportunities for players in the market. Regulatory restrictions in developed countries, however, are a major challenge faced by market players in the current immunohistochemistry market. The  immunohistochemistry market  is projected to reach USD 2.12 billion by 2021, growing at a CAGR of 7.3% during the forecast period. Antibodies segment to dominate the global immunohistochemistry market Based on products, the market is segmented into antibodies, reagents, kits, and equipment. In 2015, the antibodies segment accounted for the largest share of the global immunohistochemistry market. ...

The  immunohistochemistry market  is projected to reach USD 2.12 billion by 2021, growing at a CAGR of 7.3% during the forecast period.  Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the IVD industry, and increasing healthcare spending are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine are expected to offer significant growth opportunities for players in the market. Regulatory restrictions in developed countries, however, are a major challenge faced by market players in the current immunohistochemistry market. Antibodies segment to dominate the global immunohistochemistry market Based on products, the market is segmented into antibodies, reagents, kits, and equipment. In 2015, the antibodies segment accounted for the largest share of the global immunohistochemistry ma...

According to the new market research report " Immunohistochemistry Market by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User - Global Forecast to 2021 ", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). Don’t miss out on business opportunities in  Immunohistochemistry Market . Speak to our analyst and gain crucial industry insights that will help your business grow:  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=121632939 The immunohistochemistry market is projected to reach USD 2.12 Billion by 2021, at a CAGR of 7.3% during the forecast period. Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and increasing physi...

Rising geriatric population, growing prevalence of chronic diseases, rapid technological developments in the IVD industry, and increasing healthcare spending are expected to fuel the growth of this market in the coming years. However, rapid growth in the developing countries across APAC and Latin America and the increasing demand for personalized medicine are expected to offer significant growth opportunities for players in the immunohistochemistry market. Regulatory restrictions in developed countries, however, are a major challenge faced by market players in the current immunohistochemistry market. The  immunohistochemistry market  is segmented into antibodies, reagents, kits, and equipment. In 2015, the antibodies segment accounted for the largest share of the global immunohistochemistry market. The rising adoption of high-throughput assays, such as array comparative genomic hybridization, cDNA microarray, next-generation sequencing techniques, and histological tests, have ...

According to the new market research report  " Immunohistochemistry Market  by Product (Antibody, Reagent, Kits, Slide Staining System, Tissue Microarray) Application (Diagnostics (Cancer, Cardiovascular, Diabetes, Autoimmune, Infectious Diseases) & Drug Testing) End User - Global Forecast to 2021" , published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints/challenges, and opportunities in North America, Europe, Asia-Pacific, and the Rest of the world (RoW). Don’t miss out on business opportunities in  Immunohistochemistry Market . Speak to our analyst and gain crucial industry insights that will help your business grow:  https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=121632939 The immunohistochemistry market is projected to reach USD 2.12 Billion by 2021, at a CAGR of 7.3% during the forecast period. Rising geriatric population, growing prevalence of chronic diseases, increasing number of diagnostic centers, and incre...

Immunohistochemistry market is categorized into two application segments, namely, diagnostics and drug testing. The global immunohistochemistry market for diagnostic applications is further segmented into infectious diseases, cancer, cardiovascular diseases, diabetes, autoimmune diseases, and nephrological diseases. In 2015, the diagnostics segment accounted for the largest share of the global immunohistochemistry market. The large share of this segment is attributed to growing prevalence of cancer, and wide application of immunohistochemistry in the diagnosis of cancers, infectious diseases, cardiovascular diseases, and other diseases. North America dominates the global  immunohistochemistry market , and this trend is expected to continue during the forecast period. The large share of North America can be attributed to the fact that the majority of big players operating in the immunohistochemistry market are located in this region. In addition, the increasing geriatric population ...